Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. Cephalosporin originally derived from the fungus Acremonium, which was previously known as "Cephalosporium". According to our (Global Info Research) latest study, the global Cephalosporin market size was valued at USD 1420.7 million in 2022 and is forecast to a readjusted size of USD 1390.5 million by 2029 with a CAGR of -0.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Market competition is intense. Qilu Antibiotics, Nectar Lifesciences, Shandong Ruiying Pioneer Pharmaceutical, NCPC and ACSﾠDobfar are the top 5 of Cephalosporin, with about 50% market shares.China is the largest supplier of Cephalosporin, with a production market share nearly 70%. India is the second largest supplier of Cephalosporin, enjoying production market share nearly 21%.China is the largest consumption place, with a consumption market share nearly 40%. Following China, India is the second largest consumption place with the consumption market share of 39%. The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation is about 61%.Cephalosporin is widely used in d Oral drugs and Injection drugs. The most proportion of Cephalosporin is Injection drugs, and the consumption proportion is about 80%. This report is a detailed and comprehensive analysis for global Cephalosporin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Cephalosporin market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029 Global Cephalosporin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029 Global Cephalosporin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029 Global Cephalosporin market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Cephalosporin To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Cephalosporin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals and Hospira, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market Segmentation Cephalosporin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type First Generation Cephalosporin Second Generation Cephalosporin Third Generation Cephalosporin Fourth Generation Cephalosporin Market segment by Application Oral Injection Major players covered Union Chempharma NCPC Qilu Antibiotics Lupin Pharmaceuticals Hospira Dhanuka Laboratories Fukang Dongying Pharmaceutical Alkem SALUBRIS LIVZON Hetero Drugs CSPC TEVA Orchid Pharma Taj Pharmaceuticals Covalent Laboratories United Laboratories Aurobindo Wockhardt LKPC HPGC Huafangpharm Liaoning Medya Pharmaceutical. Sichuan Kelun Pharmaceutical Suzhou Dawnrays Pharmaceutical Fuan Pharmaceutical Harbin Pharmaceutical Group Shandong Ruiying Pioneer Pharmaceutical Guangdong Liguo Pharmaceutical Nectar Lifesciences ACS Dobfar Novartis Market segment by region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Cephalosporin product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Cephalosporin, with price, sales, revenue and global market share of Cephalosporin from 2018 to 2023. Chapter 3, the Cephalosporin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Cephalosporin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cephalosporin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029. Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War. Chapter 13, the key raw materials and key suppliers, and industry chain of Cephalosporin. Chapter 14 and 15, to describe Cephalosporin sales channel, distributors, customers, research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Cephalosporin 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Cephalosporin Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 First Generation Cephalosporin 1.3.3 Second Generation Cephalosporin 1.3.4 Third Generation Cephalosporin 1.3.5
